VisualSonics presents the first episode of their Vevo 4 Photoacoustics Web Series.
Combined Near Infrared Photoacoustic Imaging and Ultrasound Detects Vulnerable Atherosclerotic Plaque with Martin Schneider, MD, PhD from Stanford University.
Key Topics Include:
- Visualization of atherosclerotic plaque components with high-frequency ultrasound and photoacoustics
- Identification of photoacoustic biomarkers for atherosclerosis
- Distinguishing stable from vulnerable plaques
- Clinical significance of novel photoacoustic-detection methods
Who Should Attend?
Open to those studying vascular diseases or those interested in learning about new methods of non-invasive molecular imaging (all educational/experience levels are invited).
Presenters
Postdoctoral Fellow
Radiology
Stanford University School of Medicine
Martin Schneider joined the Gambhir Lab at Stanford in 2019 where he worked on optical phantoms and clinical photoacoustic imaging trials. He received the Cardiovascular Award from FUJIFILM VisualSonics.
Webinar Host
FUJIFILM VisualSonics Inc.
FUJIFILM VisualSonics designs and manufactures ultra high frequency in vivo imaging systems, for both research and clinical use. our ultrasound platform provides images at resolutions that far exceed any other system available on the market. Beyond ultrasound, we have also developed a unique photoacoustic technology to expand on the capabilities of our imaging solutions.
Additional Content From FUJIFILM VisualSonics Inc.
Illuminating the Brain: Advances in Neurobiology
Watch leading experts in neurobiology imaging in a virtual symposium exploring cutting-edge multi-modal approaches using ultra-high frequency ultrasound and photoacoustics.
The Sound of Science: Mapping the Tumor Microenvironment for Advanced Therapeutic Strategies
Unlock the full potential of photoacoustic imaging (PAI) for evaluation of the tumor microenvironment at VisualSonics' Advanced Photoacoustic Imaging Workshop.
Vevo Ask The Experts: Oncology Imaging
Experts at FUJIFILM VisualSonics explore how the Vevo F2 can advance oncology research through high-resolution ultrasound and photoacoustic imaging.